Table 4

Comparison of patients with Crohn’s disease treated with enteral nutrition (n=12, 7M/5F) or prednisolone (n=12, 10M/2F)

	Treatment	0 Months	One month	Three months
Age (y)	Enteral nutrition	12.8 (15.9)	–	–
	Prednisolone	13.95 (1.8)	–	–
Height (cm)	Enteral nutrition	147.2 (15.9)	147.0 (17.3)	147.1 (16.7)
	Prednisolone	156.7 (9.9)	157.0 (9.5)	156.6 (10.7)
Weight (kg)	Enteral nutrition	32.6 (8.8)^a	38.2 (11.7)^b	40.9 (12.1)^c
	Prednisolone	41.0 (9.0)^a	47.3 (9.0)^b	51.4 (10.3)^c
IBW (%)	Enteral nutrition	83.9 (11.3)^a	97.9 (15.8)^b	106 (13.8)^c
	Prednisolone	89.1 (9.8)^a	103.9 (15.6)^b	114.2 (17.9)^c
REE (kcal/day)	Enteral nutrition	1153 (283)^a	1415 (535)^b	1453 (307)^c
	Prednisolone	1380 (308)^a	1432 (265)^a	1592 (362)^b
REE (% predicted)	Enteral nutrition	96.6 (13.1)^a	108.7 (21)^A,b	110 (114.4)^{B, b}
	Prednisolone	100.8 (15.9)	97.4 (13.6)^C	102.9 (16.2)^D
LBM	Enteral nutrition	27.56 (10.1)^a	32.5 (11.6)^b	34.7 (10.6)^c
	Prednisolone	34.5 (8.2)^a	39.06 (10.7)^b	38.9 (10.8)^b
LBM (%wt)	Enteral nutrition	86.6 (8.9)	88.8 (9.9)	83.2 (5.7)
	Prednisolone	87.5 (9.4)	79.1 (9.4)	77.7 (11.4)
Fat (%wt)	Enteral nutrition	16.19 (4.7)^a	20.8 (5.2)^b	22.0 (5.7)^c
	Prednisolone	17.4 (4.0)^a	20.5 (5.5)^b	24.1 (5.9)^c
TBW (L)	Enteral nutrition	20.12 (4.8)^a	23.7 (8.4)^A,b	25.4 (7.8)^B,c
	Prednisolone	25.2 (6.0)^a	25.8 (7.8)^C,b	28.4 (7.9)^D,b
ECW (L)	Enteral nutrition	9.24 (2.7)^a	9.2 (4.7)^A,b	10.7 (5.5)^B,c
	Prednisolone	11.07 (2.3)^a	12.8 (2.3)^C,b	11.56 (2.7)^D,c
ICW (L)	Enteral nutrition	10.6 (3.1)^a	13.5 (4.9)^b	13.9 (4.7)^A,b
	Prednisolone	14.1 (4.9)^a	17.8 (4.56)^b	16.9 (5.6)^B,b
ECW (%wt)	Enteral nutrition	29.0 (3.5)^a	25.2 (8.9)^b	25.4 (10.3)^b
	Prednisolone	28.4 (4.7)^a	25.0 (2.7)^b	23.1 (2.5)^c
ECW/ICW	Enteral nutrition	0.94 (0.27)^a	0.77 (0.09)^b	0.73 (0.33)^b
	Prednisolone	0.88 (0.45)	0.73 (0.12)	0.72 (0.16)

Values are expressed as mean (SD).
0 Months, before treatment; one month, one month after treatment; three months, three months after treatment.
There was no statistically significant difference between the two groups before treatment.
IBW, ideal body weight; REE, resting energy expenditure; LBM, lean body mass; TBW, total body water; ICW, intracellular water; ECW, extracellular water.
Lower case superscript letters denote comparisons within subject across the 0, one and three month time points in each of the two treatment groups. Means with different superscripts are significantly different (p<0.05).
Differences in the response to treatment between treatment groups (enterally fed compared with prednisolone treated) are shown using superscript capital letters. Responses to treatment were tested as the changes from before treatment (0 months) to either one month or three months. Means with different superscripts are significantly different (p<0.05).